Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules

Journal of Viral Hepatitis

Volumn 10, Issue 3, 2003, Pages 234-239

  Tallis, Graham F ^a,e   Ryan, Genevieve M ^a,d   Lambert, S B ^a,c   Bowden, D S ^b   McCaw, R ^b   Birch, C J ^b   Moloney, M ^a   Carnie, J A ^a   Locarnini, S A ^b   Rouch, G J ^a   Catton, M G ^b  

^a Dept of Human Services Victoria ^*  (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Hlthcare Risk Rsrc International   (Australia)

^e Australian Government Department of Human Services   (Australia)

Author keywords

Anaesthetic ampoules; Arthroscopy; Endoscopy; Hepatitis C; Phylogenetic analysis

Indexed keywords

ANESTHETIC AGENT; FENTANYL; HEPATITIS C ANTIBODY; PROPOFOL; VIRUS RNA;

ADULT; AMPOULE; ANESTHETIC EQUIPMENT; ARTHROSCOPY; CASE REPORT; COLONOSCOPY; DISINFECTION; DRUG CONTAMINATION; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSTRUMENT STERILIZATION; MEDICAL INSTRUMENTATION; MEDICAL STAFF; PHYLOGENY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RNA SEQUENCE; SERUM; SYRINGE; VIRUS TRANSMISSION;

ADULT; ANESTHETICS, INTRAVENOUS; ARTHROSCOPY; CROSS INFECTION; DRUG PACKAGING; ENDOSCOPY; EQUIPMENT CONTAMINATION; FEMALE; FENTANYL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MIDDLE AGED; PHYLOGENY; PROPOFOL; RNA, VIRAL;

EID: 0037565529     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00424.x     Document Type: Review

References (23)

1. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes and cofactors. Epidemiol Rev 1996; 18: 137-148.
2. Chant K, Kociuba K, Munro R et al. Investigation of possible patient-to-patient transmission of hepatitis C in a hospital. New South Wales Public Health Bull 1994; 5: 47-51. Available at http://www.health.nsw.gov.au/public-health/phb/phbmay94.pdf checked 28 May 2002.
3. Bronowicki J-P, Venard V, Botté C et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997; 337: 237-240.
4. Massari M, Petrosillo N, Ippolito G et al. Transmission of hepatitis C virus in a gynecological surgery setting. J Clin Micro 2001: 39: 2860-2863.
5. Public Health Division Department of Human Services, Management, Control and Prevention of Hepatitis C: A Strategy for Victoria. Melbourne: Department of Human Services. Victoria, 1995; 1-41. Available at http://www. dhs.vic.gov.au/phd/hprot/hcv/hcvtitle.html checked 28 May 2002.
6. Crofts N, Hopper J, Bowden D, Breschkin A, Milner R, Locarnini S. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-241.
7. Feldenstein J. PHYLIP: Phylogenetic Inference Package. Version 3.572. Seattle: University of Washington. Department of Genetics, 1993.
8. McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J Viral Hepatitis 1997; 4: 351-357.
9. Druce JD, Catton MG, Ryan G, Birch CJ. Survival of hepatitis C surrogate in anaesthetic and analgesic drugs. Aust Infect Control 2001: 6: 89-90.
10. Andrews R, Curran M. Enhanced surveillance for incidence cases of hepatitis C in Australia. 1995. Comm Dis Intell 1996; 20: 384-388.
11. Widell A, Christensson B, Wiebe T et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 1999; 130: 130-134.
12. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection. Scand J Infect Dis 1997; 29: 23-28.
13. Elghouzzi MH, Bouchardeau F, Pillonel J et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 2000: 79(3): 138-144.
14. Merle V, Goria O, Gourier-Frery C et al. Risk factors of contamination by hepatitis C virus. Case-control study in the general population, Gastroenterol Clin Biol 1999 Apr; 23(4): 439-446.
15. Alter M, Ahtone J, Maynard J. Hepatitis B virus transmission associated with a multiple-dose ampoule in a hemodialysis unit. Ann Intern Med 1983; 99: 330-333.
16. Druce J, Locarnini S, Birch C. Isolation of HIV-1 from experimentally contaminated multi-dose local anaesthetic ampoules. Med J Aust 1995; 162: 513-515.
17. Mortimer PP. Away with multi-use ampoules! [editorial; comment]. Aids 1999: 13: 1779-1781.
18. Schvarcz R, Johansson B, Nystrom B, Sonnerborg A. Nosocomial transmission of hepatitis C virus. Infection 1997; 25: 74-77.
19. Lutz C, Bell C, Wedner H, Krogstad D. Allergy testing of multiple patients should no longer be performed with a common syringe. N Engl J Med 1984; 310: 1335-1337.
20. Parlow J. Blood contamination of drug syringes used in anaesthesia. Can J Anaesth 1989; 36(suppl): S61-S62.
21. Shields J. Patient-to-patient transmission of HIV [letter]. Lancet 1994; 343: 415.
22. Chant K, Lowe D. Rubin G et al. Patient-to-patient transmission of HIV in private surgical consulting rooms [letter]. Lancet 1993; 342: 1548-1549.
23. Chant K, Lowe D, Rubin G, Manning W. Patient-to-patient transmission of HIV (letter: comment). Lancet 1994: 343: 415-416.